Linda Neuman's most recent trade in Aeglea BioTherapeutics Inc was a trade of 550,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 23, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aeglea BioTherapeutics Inc | Linda Neuman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 550,000 | 550,000 | - | - | Employee Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Linda Neuman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) |